by Katie McLean on (#5BV6F)
Each year, the flu vaccine has to be redesigned to account for new mutations. Researchers at MIT and the Ragon Institute of MIT, Mass. General, and Harvard are hoping for a better way. The problem is that while the vaccine prompts production of antibodies against the flu virus, those antibodies tend to target a viral…